Why the study?
The relationship between hospital price markups and risk-adjusted perioperative quality, safety outcomes, discharge disposition, and resource utilization across high-risk major operations remained poorly defined.
Does treatment at high-markup hospitals increase postoperative complications, non-home discharge, and costs in adults undergoing major surgery?
Does treatment at high-markup hospitals increase postoperative complications, non-home discharge, and costs in adults undergoing major surgery?
Higher hospital price markups are associated with increased rates of complications, non-home discharge, and markedly higher costs for major surgeries, highlighting the need for value-based payment models.
No takes yet. Share an insight, caveat, or question.
High-markup hospitals may warrant referral caution for major surgery; leaves open whether pricing strategies drive or merely mark poorer quality.
Introduction: Substantial variation in hospital price markups has raised concerns regarding value and equity in inpatient care.Markup levels may capture organizational pricing strategies and local market dynamics; however, in contemporary all-payer national cohorts spanning multiple high-risk major operations, their relationship with risk-adjusted perioperative quality and safety outcomes, discharge disposition, and resource utilization remains poorly defined.Methods: Using the National Inpatient Sample (2016-2019), adults (aged 18 years) undergoing coronary artery bypass grafting, abdominal aortic aneurysm repair, pneumonectomy, or major gastrointestinal surgery were identified.Hospitals were categorized into low-markup hospital, moderate-markup hospital, and high-markup hospital categories.Outcomes included postoperative complications, length of stay, in-hospital mortality, non-home discharge, and total costs.Results: Among 600,828 patients (coronary artery bypass grafting: 26.0%; abdominal aortic aneurysm repair: 13.2%; pneumonectomy: 8.2%; major gastrointestinal: 52.0%), 23.3% (n = 139,991) were treated at low-markup hospitals, 37.2% (n = 223,468) at moderate-markup hospitals, and 39.5% (n = 237,369) at high-markup hospitals.A total of 4,764 hospitals were included; high-markup hospitals were more often medium or large in size (high-markup hospitals: 65.2%; moderate-markup hospitals: 63.2%; lowmarkup hospitals: 53.7%), urban (high-markup hospitals: 86.2%; moderate-markup hospitals: 76.9%; low-markup hospitals: 54.9%), and for-profit (high-markup hospitals: 36.0%;moderate-markup hospitals: 12.1%; low-markup hospitals: 5.1%) (all P < .001).Major surgery at high-markup hospitals was associated with higher odds of in-hospital morbidity (adjusted odds ratio, 1.07 [1.05-1.08]),non-home discharge (adjusted odds ratio, 1.07 [1.06-1.09]),and 50.3% higher index hospitalization costs compared with low-markup hospitals.Surgery at moderate-markup hospitals was linked with greater odds of complications (adjusted odds ratio, 1.03 [1.01-1.05]),in-hospital mortality (adjusted odds ratio, 1.07 [1.03-1.12]),and 24.7% higher costs (24.2%-25.3%).Conclusion: Higher hospital markups were predominantly observed among for-profit institutions.Highmarkup hospitals demonstrated higher rates of complications, non-home discharge, longer hospital stays, and markedly higher costs.Greater price transparency and payment models that reward quality and value rather than charges are necessary to promote equitable and affordable care.
Angez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: